Home › Compare › SYEV vs MRK

SYEV vs MRK: Dividend Comparison 2026

SYEV yields 222222.22% · MRK yields 3.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SYEV wins by $1.4076447531278624e+30M in total portfolio value
10 years
SYEV
SYEV
● Live price
222222.22%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.4076447531278624e+30M
Annual income
$1,406,399,782,569,334,400,000,000,000,000,000,000.00
Full SYEV calculator →
MRK
Merck & Co. Inc.
● Live price
3.25%
Share price
$94.80
Annual div
$3.08
5Y div CAGR
8.2%
Payout ratio
42%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.7K
Annual income
$950.29
Full MRK calculator →

Portfolio growth — SYEV vs MRK

📍 SYEV pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSYEVMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SYEV + MRK cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
SYEV pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SYEV
Annual income on $10K today (after 15% tax)
$18,888,888.89/yr
After 10yr DRIP, annual income (after tax)
$1,195,439,815,183,934,200,000,000,000,000,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$276.16/yr
After 10yr DRIP, annual income (after tax)
$807.75/yr
At 15% tax rate, SYEV beats the other by $1,195,439,815,183,934,200,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SYEV + MRK for your $10,000?

SYEV: 50%MRK: 50%
100% MRK50/50100% SYEV
Portfolio after 10yr
$7.038223765639312e+29M
Annual income
$703,199,891,284,667,200,000,000,000,000,000,000.00/yr
Blended yield
99.91%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

SYEV
No analyst data
Altman Z
-0.4
Piotroski
2/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+35.6% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SYEV buys
0
MRK buys
0
No recent congressional trades found for SYEV or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSYEVMRK
Forward yield222222.22% ✓3.25%
Annual dividend / share$2.00$3.08 ✓
Payout ratio50%42% ✓
1-year div growth0%5.5% ✓
5-year div CAGR0%8.2% ✓
Portfolio after 10y$1.4076447531278624e+30M$30.7K ✓
Annual income after 10y$1,406,399,782,569,334,400,000,000,000,000,000,000.00 ✓$950.29
Total dividends collected$1.4075632434891558e+30M$6.1K ✓
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: SYEV vs MRK ($10,000, DRIP)

YearSYEV PortfolioSYEV Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$22,232,922$22,222,222.22$11,192$351.54+$22.22M → SYEV
2$46,198,082,523$46,174,293,296.41$12,524$392.70+$46198.07M → SYEV
3$89,718,752,943,223$89,669,320,994,923.30$14,015$438.65+$89718752.93M → SYEV
4$162,845,393,609,755,680$162,749,394,544,106,430.00$15,682$489.96+$162845393609.74M → SYEV
5$276,249,735,879,778,500,000$276,075,491,308,616,120,000.00$17,547$547.23+$276249735879778.47M → SYEV
6$437,989,462,258,048,500,000,000$437,693,875,040,657,100,000,000.00$19,632$611.16+$437989462258048512.00M → SYEV
7$649,026,142,700,674,900,000,000,000$648,557,493,976,058,700,000,000,000.00$21,963$682.53+$649026142700674875392.00M → SYEV
8$898,874,153,179,794,200,000,000,000,000$898,179,695,207,104,400,000,000,000,000.00$24,571$762.18+$8.988741531797941e+23M → SYEV
9$1,163,523,886,474,633,300,000,000,000,000,000$1,162,562,091,130,731,000,000,000,000,000,000.00$27,486$851.08+$1.1635238864746333e+27M → SYEV
10$1,407,644,753,127,862,300,000,000,000,000,000,000$1,406,399,782,569,334,400,000,000,000,000,000,000.00$30,745$950.29+$1.4076447531278624e+30M → SYEV

SYEV vs MRK: Complete Analysis 2026

SYEV — Stock

Seychelle Environmental Technologies, Inc. designs, assembles, and distributes absorption micron filters for portable filter devices worldwide. Its products include flip-top and pull top bottles, canteens, water pitchers, pure water pumps, stainless steel bottles, in-line filters, pure water bags, pure water pouches, and pure water straws, as well as Pump N' Pure. The company sells its products to individuals, dealers, distributors, multilevel marketing companies and missionaries, non-governmental organizations, and emergency relief organizations. It also sells its products as a private label supplier. The company was formerly known as Royal Net, Inc. and changed its name to Seychelle Environmental Technologies, Inc. in January 1998. Seychelle Environmental Technologies, Inc. was incorporated in 1986 and is based in Aliso Viejo, California.

Full SYEV Calculator →

MRK — Healthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →
📬

Get this SYEV vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SYEV vs SCHDSYEV vs JEPISYEV vs OSYEV vs KOSYEV vs MAINSYEV vs JNJSYEV vs ABBVSYEV vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.